Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

22 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Requip XL Articles

Warner Chilcott sues Watson over Lo Loestrin; Actavis debuts generic Requip

20 May 2012

GSK's 3rd-qtr 2008 profit down 21.6% as generics lead to 13% US sales decline

27 October 2008

Skyepharma further reduces loss in first half

8 September 2008

Stock Commentary - Europe - week to June 23, 2008

30 June 2008

Stock Commentary - Europe - week to June 16, 2008

23 June 2008

FDA approval for GSK

23 June 2008

GSK launches once-daily ReQuip XL in UK

19 May 2008

GSK's 1st-qtr 2008 EPS drops 5% on Avandia sales slump and generic competition

28 April 2008

FDA extends decision date on Requip XL to 2nd-qtr 2008

11 February 2008

Requip gets US FDA "approvable" letter

17 December 2007

GSK/SkyePharma file Requip XL with US FDA

23 April 2007

GSK's Requip cuts off time in PD patients

16 April 2007

Showing 1-12 of 12 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Is failure to adopt business process management putting the pharma industry at risk?
  • Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
  • New Zealand declines Alexion's funding application for Solaris
  • HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
  • Elan makes "transformational" acquisitions and a divestment
  • Is failure to adopt business process management putting the pharma industry at risk?
  • Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
  • New Zealand declines Alexion's funding application for Solaris
  • HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
  • Elan makes "transformational" acquisitions and a divestment

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS